<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0011">
 <label>11.</label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>Bourliere</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Gordon</surname>
   <given-names>SC</given-names>
  </string-name>, 
  <string-name>
   <surname>Flamm</surname>
   <given-names>SL</given-names>
  </string-name>, et al. 
  <article-title>Sofosbuvir, velpatasvir, and voxilaprevir for previously treated HCV infection</article-title>. 
  <source>
   <italic toggle="yes">N Engl J Med</italic>
  </source>. 
  <year>2017</year>;
  <volume>376</volume>(
  <issue>22</issue>):
  <fpage>2134</fpage>â€“
  <lpage>2146</lpage>. doi:
  <pub-id pub-id-type="doi">10.1056/NEJMoa1613512</pub-id>
  <pub-id pub-id-type="pmid">28564569</pub-id>
 </mixed-citation>
</ref>
